WHY WE NEED YOU
Since 1994, with the support of the community, NBCF has invested $181 million in Australia into 557 world-class research projects.
The five-year survival rate in that time has increased from 76% to 91%. The number of women being diagnosed in their lifetime
has dropped from 1 in 8 to 1 in 7.
Breast cancer is still the most diagnosed cancer in Australia however and its incidence is increasing: 19,535 will be diagnosed this year - 53 Australians every day of 2020.
8 women die from breast cancer each day.
By making a pledge to GO PINK and raising funds this June, you can take a stand against breast cancer - and help the National Breast Cancer Foundation fund more world-class research, research that will detect tumours earlier, improve outcomes and save lives.
Make your pledge today!
YOU'LL BE HELPING SAVE LIVES
WOMEN WILL BE
BREAST CANCER IN
WOMEN DIE FROM
BREAST CANCER EVERY
DAY IN AUSTRALIA
BE DIAGNOSED IN
THE IMPACT OF YOUR FUNDRAISING
Helps fund researchers develop training tools for radiologists to improve the accuracy of breast cancer screenings
Helps fund researchers investigate how changes in the immune system can increase the risk of breast cancer
Helps fund researchers identify new non-genetic risk factors for breast cancer
Helps researchers identify other DNA defects that may contribute to the development of breast cancer
WHO YOU’RE HELPING FUND
PROFESSOR KELLY-ANNE PHILLIPS
Peter MacCallum Cancer Centre, VIC
EMPOWERING WOMEN WITH BREAST CANCER TO
MAKE BETTER INFORMED TREATMENT DECISIONS
Some women who have breast cancer consider undergoing a double mastectomy to remove all breast tissue. This decision is a complex one and it is important that women make it using information that is personalised to their situation.
A new online tool called iPreventNext, being developed by a team led by Professor Kelly-Anne Phillips, will use the latest knowledge about breast cancer risk and decision-making to help women make this challenging decision.
DR TU NGUYEN-DUMONT
Monash University, VIC
UNDERSTANDING GENETIC LINKS
Genetic testing is the most effective way for women and their families to confirm if they have an inherited predisposition to breast cancer.
While new technology enables doctors to screen multiple genes for mutations at once, we have limited understanding of the variation observed in the genes included in these tests. As a result, it can be very frustrating for women with a family history of breast cancer who are left with no explanation for their risk and aren’t able to receive appropriate clinical management for themselves and their family.
PROFESSOR JOHN HOPPER
University of Melbourne
MEASURING BREAST CANCER RISK
While mammographic screenings aim to detect breast tumours, they also have the potential to detect breast cancer risk by accurately measuring breast tissue density. We’ve known for some time that higher breast tissue density means a higher risk of breast cancer.
Professor Hopper aims to examine how breast tissue density combined with lifestyle, medication, genetic factors
If individuals with the highest risk of breast cancer can be identified, they will have greater preventative options and improved long-term outcomes.
ABOUT NATIONAL BREAST CANCER FOUNDATION
National Breast Cancer Foundation (NBCF) is Australia’s leading national body funding game-changing breast cancer research with money raised entirely by the Australian public.
We receive no government funding. What we do, would not be possible without the support and generosity of people and organisations like YOU.
Our mission is simple: stop deaths from breast cancer. How? By identifying, funding and championing world-class research - research that will help us detect tumours earlier, improve treatment outcomes, and ultimately – save lives.
Since NBCF’s inception in 1994, the five-year survival rates for breast cancer has increased from 76% to 91%. It’s proof our strategy is working. More than ever, NBCF is focussing keenly on how we can do more with less in order to achieve great outcomes that will impact the longevity and quality of life for patients with breast cancer.
For us, this means identifying new and effective models of funding and ensuring that we don’t stand alone but work collaboratively and creatively to achieve our mission of zero deaths from breast cancer by 2030.